Xiao Fang Pharma

603207
21.590.42% ( -0.09 )
Delay Closed: Nov 17, 15:00:00

Financials

Q3 2026 Earnings

Financial report interval: 2026.06.30 - 2026.09.30

Overview: Xiao Fang Pharma(603207) the Revenue is 143.97 M (+12.98%);the EBIT is 54.92 M (-1.67%);the EPS is 0.301 (+0.04%).

Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.14B12.98%
----
----
EBIT
0.05B1.67%
----
----
EPS
0.30080.04%
----
----

Upcoming earnings report - FY2026 Annual Earning Release

Available dateApr 28, 2027
Estimate Revenue--
Estimate EBIT--
Estimate EPS--

Revenue

ActualEstimateUnit: CNY
Quarterly

EBIT

ActualEstimateUnit: CNY
Quarterly

Net income

ActualEstimateUnit: CNY
Quarterly

EPS

ActualEstimateUnit: CNY
Quarterly